Glycogen Assay kit provides a simple, fast and robust way to measure Glycogen levels in various biological samples. This assay is suitable for measuring Glycogen levels in samples that contain reducing substances, which may interfere with the oxidase-based assays. In this assay, Glycogen is hydrolyzed into glucose, which is oxidized to form an intermediate that reduces a colorless Probe to a colored product with strong absorbance at 450 nm. This high-throughput suitable assay kit can detect less than 4 µg/ml of Glycogen in samples.
Market Analysis and Insights: Global Glycogen Assay Kit Market
Due to the COVID-19 pandemic, the global Glycogen Assay Kit market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 3.75µM (Colorimetric) accounting for % of the Glycogen Assay Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Metabolism segment is altered to an % CAGR throughout this forecast period.
China Glycogen Assay Kit market size is valued at US$ million in 2021, while the US and Europe Glycogen Assay Kit are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glycogen Assay Kit landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Glycogen Assay Kit include Merck, Abnova, BioVision, Abcam, Cayman Chemical Company, Cell Biolabs, Novus Biologicals, BioCat GmbH and Elabscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Glycogen Assay Kit Scope and Segment
Glycogen Assay Kit market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Glycogen Assay Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
3.75µM (Colorimetric)
0.12µM (Fluorescence)
Others
Segment by Application
Metabolism
Cell Signal Analysis
Others
By Company
Merck
Abnova
BioVision
Abcam
Cayman Chemical Company
Cell Biolabs
Novus Biologicals
BioCat GmbH
Elabscience
MyBiosource
Nanjing Yixun Biological Technology
Shanghai Xinfan Biological Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE